Mammary	B:C0929301
Gland	I:C0929301
Pathology	O
Subsequent	O
to	O
Acute	O
Infection	I:C0275518
with	O
Strong	O
versus	O
Weak	O
Biofilm	O
Forming	I:C1325881
Staphylococcus	O
aureus	I:C0038172
Bovine	O
Mastitis	I:C0024895
Isolates	O
:	O
A	O
Pilot	O
Study	I:C0031928
Using	O
Non-Invasive	O
Mouse	O
Mastitis	I:C1522044
Model	O
Biofilm	O
formation	I:C1325881
by	O
Staphylococcus	O
aureus	I:C0038172
is	O
an	O
important	O
virulence	O
attribute	O
because	O
of	O
its	O
potential	O
to	O
induce	O
persistent	O
antibiotic	O
resistance	O
,	O
retard	O
phagocytosis	O
and	O
either	O
attenuate	O
or	O
promote	O
inflammation	O
,	O
depending	O
upon	O
the	O
disease	O
syndrome	I:C0012634
,	O
in	O
vivo	I:C1515655
.	O

Mammary	O
Gland	I:C0929301
Pathology	O
Subsequent	O
to	O
Acute	B:C0275518
Infection	I:C0275518
with	O
Strong	O
versus	O
Weak	O
Biofilm	O
Forming	I:C1325881
Staphylococcus	O
aureus	I:C0038172
Bovine	O
Mastitis	I:C0024895
Isolates	O
:	O
A	O
Pilot	O
Study	I:C0031928
Using	O
Non-Invasive	O
Mouse	O
Mastitis	I:C1522044
Model	O
Biofilm	O
formation	I:C1325881
by	O
Staphylococcus	O
aureus	I:C0038172
is	O
an	O
important	O
virulence	O
attribute	O
because	O
of	O
its	O
potential	O
to	O
induce	O
persistent	O
antibiotic	O
resistance	O
,	O
retard	O
phagocytosis	O
and	O
either	O
attenuate	O
or	O
promote	O
inflammation	O
,	O
depending	O
upon	O
the	O
disease	O
syndrome	I:C0012634
,	O
in	O
vivo	I:C1515655
.	O

Mammary	O
Gland	I:C0929301
Pathology	O
Subsequent	O
to	O
Acute	O
Infection	I:C0275518
with	O
Strong	O
versus	O
Weak	O
Biofilm	B:C1325881
Forming	I:C1325881
Staphylococcus	O
aureus	I:C0038172
Bovine	O
Mastitis	I:C0024895
Isolates	O
:	O
A	O
Pilot	O
Study	I:C0031928
Using	O
Non-Invasive	O
Mouse	O
Mastitis	I:C1522044
Model	O
Biofilm	O
formation	I:C1325881
by	O
Staphylococcus	O
aureus	I:C0038172
is	O
an	O
important	O
virulence	O
attribute	O
because	O
of	O
its	O
potential	O
to	O
induce	O
persistent	O
antibiotic	O
resistance	O
,	O
retard	O
phagocytosis	O
and	O
either	O
attenuate	O
or	O
promote	O
inflammation	O
,	O
depending	O
upon	O
the	O
disease	O
syndrome	I:C0012634
,	O
in	O
vivo	I:C1515655
.	O

Mammary	O
Gland	I:C0929301
Pathology	O
Subsequent	O
to	O
Acute	O
Infection	I:C0275518
with	O
Strong	O
versus	O
Weak	O
Biofilm	O
Forming	I:C1325881
Staphylococcus	B:C0038172
aureus	I:C0038172
Bovine	O
Mastitis	I:C0024895
Isolates	O
:	O
A	O
Pilot	O
Study	I:C0031928
Using	O
Non-Invasive	O
Mouse	O
Mastitis	I:C1522044
Model	O
Biofilm	O
formation	I:C1325881
by	O
Staphylococcus	O
aureus	I:C0038172
is	O
an	O
important	O
virulence	O
attribute	O
because	O
of	O
its	O
potential	O
to	O
induce	O
persistent	O
antibiotic	O
resistance	O
,	O
retard	O
phagocytosis	O
and	O
either	O
attenuate	O
or	O
promote	O
inflammation	O
,	O
depending	O
upon	O
the	O
disease	O
syndrome	I:C0012634
,	O
in	O
vivo	I:C1515655
.	O

Mammary	O
Gland	I:C0929301
Pathology	O
Subsequent	O
to	O
Acute	O
Infection	I:C0275518
with	O
Strong	O
versus	O
Weak	O
Biofilm	O
Forming	I:C1325881
Staphylococcus	O
aureus	I:C0038172
Bovine	B:C0024895
Mastitis	I:C0024895
Isolates	O
:	O
A	O
Pilot	O
Study	I:C0031928
Using	O
Non-Invasive	O
Mouse	O
Mastitis	I:C1522044
Model	O
Biofilm	O
formation	I:C1325881
by	O
Staphylococcus	O
aureus	I:C0038172
is	O
an	O
important	O
virulence	O
attribute	O
because	O
of	O
its	O
potential	O
to	O
induce	O
persistent	O
antibiotic	O
resistance	O
,	O
retard	O
phagocytosis	O
and	O
either	O
attenuate	O
or	O
promote	O
inflammation	O
,	O
depending	O
upon	O
the	O
disease	O
syndrome	I:C0012634
,	O
in	O
vivo	I:C1515655
.	O

Mammary	O
Gland	I:C0929301
Pathology	O
Subsequent	O
to	O
Acute	O
Infection	I:C0275518
with	O
Strong	O
versus	O
Weak	O
Biofilm	O
Forming	I:C1325881
Staphylococcus	O
aureus	I:C0038172
Bovine	O
Mastitis	I:C0024895
Isolates	B:C1764827
:	O
A	O
Pilot	O
Study	I:C0031928
Using	O
Non-Invasive	O
Mouse	O
Mastitis	I:C1522044
Model	O
Biofilm	O
formation	I:C1325881
by	O
Staphylococcus	O
aureus	I:C0038172
is	O
an	O
important	O
virulence	O
attribute	O
because	O
of	O
its	O
potential	O
to	O
induce	O
persistent	O
antibiotic	O
resistance	O
,	O
retard	O
phagocytosis	O
and	O
either	O
attenuate	O
or	O
promote	O
inflammation	O
,	O
depending	O
upon	O
the	O
disease	O
syndrome	I:C0012634
,	O
in	O
vivo	I:C1515655
.	O

Mammary	O
Gland	I:C0929301
Pathology	O
Subsequent	O
to	O
Acute	O
Infection	I:C0275518
with	O
Strong	O
versus	O
Weak	O
Biofilm	O
Forming	I:C1325881
Staphylococcus	O
aureus	I:C0038172
Bovine	O
Mastitis	I:C0024895
Isolates	O
:	O
A	O
Pilot	B:C0031928
Study	I:C0031928
Using	O
Non-Invasive	O
Mouse	O
Mastitis	I:C1522044
Model	O
Biofilm	O
formation	I:C1325881
by	O
Staphylococcus	O
aureus	I:C0038172
is	O
an	O
important	O
virulence	O
attribute	O
because	O
of	O
its	O
potential	O
to	O
induce	O
persistent	O
antibiotic	O
resistance	O
,	O
retard	O
phagocytosis	O
and	O
either	O
attenuate	O
or	O
promote	O
inflammation	O
,	O
depending	O
upon	O
the	O
disease	O
syndrome	I:C0012634
,	O
in	O
vivo	I:C1515655
.	O

Mammary	O
Gland	I:C0929301
Pathology	O
Subsequent	O
to	O
Acute	O
Infection	I:C0275518
with	O
Strong	O
versus	O
Weak	O
Biofilm	O
Forming	I:C1325881
Staphylococcus	O
aureus	I:C0038172
Bovine	O
Mastitis	I:C0024895
Isolates	O
:	O
A	O
Pilot	O
Study	I:C0031928
Using	O
Non-Invasive	O
Mouse	B:C1522044
Mastitis	I:C1522044
Model	O
Biofilm	O
formation	I:C1325881
by	O
Staphylococcus	O
aureus	I:C0038172
is	O
an	O
important	O
virulence	O
attribute	O
because	O
of	O
its	O
potential	O
to	O
induce	O
persistent	O
antibiotic	O
resistance	O
,	O
retard	O
phagocytosis	O
and	O
either	O
attenuate	O
or	O
promote	O
inflammation	O
,	O
depending	O
upon	O
the	O
disease	O
syndrome	I:C0012634
,	O
in	O
vivo	I:C1515655
.	O

Mammary	O
Gland	I:C0929301
Pathology	O
Subsequent	O
to	O
Acute	O
Infection	I:C0275518
with	O
Strong	O
versus	O
Weak	O
Biofilm	O
Forming	I:C1325881
Staphylococcus	O
aureus	I:C0038172
Bovine	O
Mastitis	I:C0024895
Isolates	O
:	O
A	O
Pilot	O
Study	I:C0031928
Using	O
Non-Invasive	O
Mouse	O
Mastitis	I:C1522044
Model	B:C0012644
Biofilm	O
formation	I:C1325881
by	O
Staphylococcus	O
aureus	I:C0038172
is	O
an	O
important	O
virulence	O
attribute	O
because	O
of	O
its	O
potential	O
to	O
induce	O
persistent	O
antibiotic	O
resistance	O
,	O
retard	O
phagocytosis	O
and	O
either	O
attenuate	O
or	O
promote	O
inflammation	O
,	O
depending	O
upon	O
the	O
disease	O
syndrome	I:C0012634
,	O
in	O
vivo	I:C1515655
.	O

Mammary	O
Gland	I:C0929301
Pathology	O
Subsequent	O
to	O
Acute	O
Infection	I:C0275518
with	O
Strong	O
versus	O
Weak	O
Biofilm	O
Forming	I:C1325881
Staphylococcus	O
aureus	I:C0038172
Bovine	O
Mastitis	I:C0024895
Isolates	O
:	O
A	O
Pilot	O
Study	I:C0031928
Using	O
Non-Invasive	O
Mouse	O
Mastitis	I:C1522044
Model	O
Biofilm	B:C1325881
formation	I:C1325881
by	O
Staphylococcus	O
aureus	I:C0038172
is	O
an	O
important	O
virulence	O
attribute	O
because	O
of	O
its	O
potential	O
to	O
induce	O
persistent	O
antibiotic	O
resistance	O
,	O
retard	O
phagocytosis	O
and	O
either	O
attenuate	O
or	O
promote	O
inflammation	O
,	O
depending	O
upon	O
the	O
disease	O
syndrome	I:C0012634
,	O
in	O
vivo	I:C1515655
.	O

Mammary	O
Gland	I:C0929301
Pathology	O
Subsequent	O
to	O
Acute	O
Infection	I:C0275518
with	O
Strong	O
versus	O
Weak	O
Biofilm	O
Forming	I:C1325881
Staphylococcus	O
aureus	I:C0038172
Bovine	O
Mastitis	I:C0024895
Isolates	O
:	O
A	O
Pilot	O
Study	I:C0031928
Using	O
Non-Invasive	O
Mouse	O
Mastitis	I:C1522044
Model	O
Biofilm	O
formation	I:C1325881
by	O
Staphylococcus	B:C0038172
aureus	I:C0038172
is	O
an	O
important	O
virulence	O
attribute	O
because	O
of	O
its	O
potential	O
to	O
induce	O
persistent	O
antibiotic	O
resistance	O
,	O
retard	O
phagocytosis	O
and	O
either	O
attenuate	O
or	O
promote	O
inflammation	O
,	O
depending	O
upon	O
the	O
disease	O
syndrome	I:C0012634
,	O
in	O
vivo	I:C1515655
.	O

Mammary	O
Gland	I:C0929301
Pathology	O
Subsequent	O
to	O
Acute	O
Infection	I:C0275518
with	O
Strong	O
versus	O
Weak	O
Biofilm	O
Forming	I:C1325881
Staphylococcus	O
aureus	I:C0038172
Bovine	O
Mastitis	I:C0024895
Isolates	O
:	O
A	O
Pilot	O
Study	I:C0031928
Using	O
Non-Invasive	O
Mouse	O
Mastitis	I:C1522044
Model	O
Biofilm	O
formation	I:C1325881
by	O
Staphylococcus	O
aureus	I:C0038172
is	O
an	O
important	O
virulence	B:C0042765
attribute	O
because	O
of	O
its	O
potential	O
to	O
induce	O
persistent	O
antibiotic	O
resistance	O
,	O
retard	O
phagocytosis	O
and	O
either	O
attenuate	O
or	O
promote	O
inflammation	O
,	O
depending	O
upon	O
the	O
disease	O
syndrome	I:C0012634
,	O
in	O
vivo	I:C1515655
.	O

Mammary	O
Gland	I:C0929301
Pathology	O
Subsequent	O
to	O
Acute	O
Infection	I:C0275518
with	O
Strong	O
versus	O
Weak	O
Biofilm	O
Forming	I:C1325881
Staphylococcus	O
aureus	I:C0038172
Bovine	O
Mastitis	I:C0024895
Isolates	O
:	O
A	O
Pilot	O
Study	I:C0031928
Using	O
Non-Invasive	O
Mouse	O
Mastitis	I:C1522044
Model	O
Biofilm	O
formation	I:C1325881
by	O
Staphylococcus	O
aureus	I:C0038172
is	O
an	O
important	O
virulence	O
attribute	O
because	O
of	O
its	O
potential	O
to	O
induce	O
persistent	O
antibiotic	O
resistance	O
,	O
retard	O
phagocytosis	B:C0031308
and	O
either	O
attenuate	O
or	O
promote	O
inflammation	O
,	O
depending	O
upon	O
the	O
disease	O
syndrome	I:C0012634
,	O
in	O
vivo	I:C1515655
.	O

Mammary	O
Gland	I:C0929301
Pathology	O
Subsequent	O
to	O
Acute	O
Infection	I:C0275518
with	O
Strong	O
versus	O
Weak	O
Biofilm	O
Forming	I:C1325881
Staphylococcus	O
aureus	I:C0038172
Bovine	O
Mastitis	I:C0024895
Isolates	O
:	O
A	O
Pilot	O
Study	I:C0031928
Using	O
Non-Invasive	O
Mouse	O
Mastitis	I:C1522044
Model	O
Biofilm	O
formation	I:C1325881
by	O
Staphylococcus	O
aureus	I:C0038172
is	O
an	O
important	O
virulence	O
attribute	O
because	O
of	O
its	O
potential	O
to	O
induce	O
persistent	O
antibiotic	O
resistance	O
,	O
retard	O
phagocytosis	O
and	O
either	O
attenuate	O
or	O
promote	O
inflammation	B:C0021368
,	O
depending	O
upon	O
the	O
disease	O
syndrome	I:C0012634
,	O
in	O
vivo	I:C1515655
.	O

Mammary	O
Gland	I:C0929301
Pathology	O
Subsequent	O
to	O
Acute	O
Infection	I:C0275518
with	O
Strong	O
versus	O
Weak	O
Biofilm	O
Forming	I:C1325881
Staphylococcus	O
aureus	I:C0038172
Bovine	O
Mastitis	I:C0024895
Isolates	O
:	O
A	O
Pilot	O
Study	I:C0031928
Using	O
Non-Invasive	O
Mouse	O
Mastitis	I:C1522044
Model	O
Biofilm	O
formation	I:C1325881
by	O
Staphylococcus	O
aureus	I:C0038172
is	O
an	O
important	O
virulence	O
attribute	O
because	O
of	O
its	O
potential	O
to	O
induce	O
persistent	O
antibiotic	O
resistance	O
,	O
retard	O
phagocytosis	O
and	O
either	O
attenuate	O
or	O
promote	O
inflammation	O
,	O
depending	O
upon	O
the	O
disease	B:C0012634
syndrome	I:C0012634
,	O
in	O
vivo	I:C1515655
.	O

Mammary	O
Gland	I:C0929301
Pathology	O
Subsequent	O
to	O
Acute	O
Infection	I:C0275518
with	O
Strong	O
versus	O
Weak	O
Biofilm	O
Forming	I:C1325881
Staphylococcus	O
aureus	I:C0038172
Bovine	O
Mastitis	I:C0024895
Isolates	O
:	O
A	O
Pilot	O
Study	I:C0031928
Using	O
Non-Invasive	O
Mouse	O
Mastitis	I:C1522044
Model	O
Biofilm	O
formation	I:C1325881
by	O
Staphylococcus	O
aureus	I:C0038172
is	O
an	O
important	O
virulence	O
attribute	O
because	O
of	O
its	O
potential	O
to	O
induce	O
persistent	O
antibiotic	O
resistance	O
,	O
retard	O
phagocytosis	O
and	O
either	O
attenuate	O
or	O
promote	O
inflammation	O
,	O
depending	O
upon	O
the	O
disease	O
syndrome	I:C0012634
,	O
in	B:C1515655
vivo	I:C1515655
.	O

This	O
study	O
was	O
undertaken	O
to	O
evaluate	O
the	O
potential	O
significance	O
of	O
strength	O
of	O
biofilm	B:C1325881
formation	I:C1325881
by	O
clinical	O
bovine	O
mastitis	I:C0024895
-	O
associated	O
S.	O
aureus	I:C0038172
in	O
mammary	O
tissue	O
damage	I:C0010957
by	O
using	O
a	O
mouse	O
mastitis	I:C1522044
model	O
.	O

This	O
study	O
was	O
undertaken	O
to	O
evaluate	O
the	O
potential	O
significance	O
of	O
strength	O
of	O
biofilm	O
formation	I:C1325881
by	O
clinical	O
bovine	B:C0024895
mastitis	I:C0024895
-	O
associated	O
S.	O
aureus	I:C0038172
in	O
mammary	O
tissue	O
damage	I:C0010957
by	O
using	O
a	O
mouse	O
mastitis	I:C1522044
model	O
.	O

This	O
study	O
was	O
undertaken	O
to	O
evaluate	O
the	O
potential	O
significance	O
of	O
strength	O
of	O
biofilm	O
formation	I:C1325881
by	O
clinical	O
bovine	O
mastitis	I:C0024895
-	O
associated	O
S.	B:C0038172
aureus	I:C0038172
in	O
mammary	O
tissue	O
damage	I:C0010957
by	O
using	O
a	O
mouse	O
mastitis	I:C1522044
model	O
.	O

This	O
study	O
was	O
undertaken	O
to	O
evaluate	O
the	O
potential	O
significance	O
of	O
strength	O
of	O
biofilm	O
formation	I:C1325881
by	O
clinical	O
bovine	O
mastitis	I:C0024895
-	O
associated	O
S.	O
aureus	I:C0038172
in	O
mammary	B:C0006141
tissue	O
damage	I:C0010957
by	O
using	O
a	O
mouse	O
mastitis	I:C1522044
model	O
.	O

This	O
study	O
was	O
undertaken	O
to	O
evaluate	O
the	O
potential	O
significance	O
of	O
strength	O
of	O
biofilm	O
formation	I:C1325881
by	O
clinical	O
bovine	O
mastitis	I:C0024895
-	O
associated	O
S.	O
aureus	I:C0038172
in	O
mammary	O
tissue	B:C0010957
damage	I:C0010957
by	O
using	O
a	O
mouse	O
mastitis	I:C1522044
model	O
.	O

This	O
study	O
was	O
undertaken	O
to	O
evaluate	O
the	O
potential	O
significance	O
of	O
strength	O
of	O
biofilm	O
formation	I:C1325881
by	O
clinical	O
bovine	O
mastitis	I:C0024895
-	O
associated	O
S.	O
aureus	I:C0038172
in	O
mammary	O
tissue	O
damage	I:C0010957
by	O
using	O
a	O
mouse	B:C1522044
mastitis	I:C1522044
model	O
.	O

This	O
study	O
was	O
undertaken	O
to	O
evaluate	O
the	O
potential	O
significance	O
of	O
strength	O
of	O
biofilm	O
formation	I:C1325881
by	O
clinical	O
bovine	O
mastitis	I:C0024895
-	O
associated	O
S.	O
aureus	I:C0038172
in	O
mammary	O
tissue	O
damage	I:C0010957
by	O
using	O
a	O
mouse	O
mastitis	I:C1522044
model	B:C0012644
.	O

Two	O
S.	B:C0038172
aureus	I:C0038172
strains	O
of	O
the	O
same	O
capsular	O
phenotype	O
with	O
different	O
biofilm	O
forming	I:C1325881
strengths	O
were	O
used	O
to	O
non-invasively	O
infect	O
mammary	O
glands	I:C0929301
of	O
lactating	O
mice	O
.	O

Two	O
S.	O
aureus	I:C0038172
strains	O
of	O
the	O
same	O
capsular	B:C0205151
phenotype	O
with	O
different	O
biofilm	O
forming	I:C1325881
strengths	O
were	O
used	O
to	O
non-invasively	O
infect	O
mammary	O
glands	I:C0929301
of	O
lactating	O
mice	O
.	O

Two	O
S.	O
aureus	I:C0038172
strains	O
of	O
the	O
same	O
capsular	O
phenotype	O
with	O
different	O
biofilm	B:C1325881
forming	I:C1325881
strengths	O
were	O
used	O
to	O
non-invasively	O
infect	O
mammary	O
glands	I:C0929301
of	O
lactating	O
mice	O
.	O

Two	O
S.	O
aureus	I:C0038172
strains	O
of	O
the	O
same	O
capsular	O
phenotype	O
with	O
different	O
biofilm	O
forming	I:C1325881
strengths	O
were	O
used	O
to	O
non-invasively	O
infect	O
mammary	B:C0929301
glands	I:C0929301
of	O
lactating	O
mice	O
.	O

Two	O
S.	O
aureus	I:C0038172
strains	O
of	O
the	O
same	O
capsular	O
phenotype	O
with	O
different	O
biofilm	O
forming	I:C1325881
strengths	O
were	O
used	O
to	O
non-invasively	O
infect	O
mammary	O
glands	I:C0929301
of	O
lactating	B:C2828358
mice	O
.	O

Two	O
S.	O
aureus	I:C0038172
strains	O
of	O
the	O
same	O
capsular	O
phenotype	O
with	O
different	O
biofilm	O
forming	I:C1325881
strengths	O
were	O
used	O
to	O
non-invasively	O
infect	O
mammary	O
glands	I:C0929301
of	O
lactating	O
mice	B:C1522424
.	O

Biofilm	B:C1325881
forming	I:C1325881
potential	O
of	O
these	O
strains	O
were	O
determined	O
by	O
tissue	O
culture	I:C0040284
plate	I:C0040284
method	I:C0040284
,	O
ica	O
typing	O
and	O
virulence	O
gene	O
profile	O
per	O
detection	O
by	O
PCR	O
.	O

Biofilm	O
forming	I:C1325881
potential	O
of	O
these	O
strains	O
were	O
determined	O
by	O
tissue	B:C0040284
culture	I:C0040284
plate	I:C0040284
method	I:C0040284
,	O
ica	O
typing	O
and	O
virulence	O
gene	O
profile	O
per	O
detection	O
by	O
PCR	O
.	O

Biofilm	O
forming	I:C1325881
potential	O
of	O
these	O
strains	O
were	O
determined	O
by	O
tissue	O
culture	I:C0040284
plate	I:C0040284
method	I:C0040284
,	O
ica	O
typing	O
and	O
virulence	B:C0042765
gene	O
profile	O
per	O
detection	O
by	O
PCR	O
.	O

Biofilm	O
forming	I:C1325881
potential	O
of	O
these	O
strains	O
were	O
determined	O
by	O
tissue	O
culture	I:C0040284
plate	I:C0040284
method	I:C0040284
,	O
ica	O
typing	O
and	O
virulence	O
gene	O
profile	O
per	O
detection	O
by	O
PCR	B:C0032520
.	O

Delivery	O
of	O
the	O
infectious	O
dose	O
of	O
S.	B:C0038172
aureus	I:C0038172
was	O
directly	O
through	O
the	O
teat	O
lactiferous	O
duct	I:C0222613
without	O
invasive	O
scraping	O
of	I:C0405377
the	I:C0405377
teat	I:C0405377
surface	I:C0405377
.	O

Delivery	O
of	O
the	O
infectious	O
dose	O
of	O
S.	O
aureus	I:C0038172
was	O
directly	O
through	O
the	O
teat	B:C0222632
lactiferous	O
duct	I:C0222613
without	O
invasive	O
scraping	O
of	I:C0405377
the	I:C0405377
teat	I:C0405377
surface	I:C0405377
.	O

Delivery	O
of	O
the	O
infectious	O
dose	O
of	O
S.	O
aureus	I:C0038172
was	O
directly	O
through	O
the	O
teat	O
lactiferous	B:C0222613
duct	I:C0222613
without	O
invasive	O
scraping	O
of	I:C0405377
the	I:C0405377
teat	I:C0405377
surface	I:C0405377
.	O

Delivery	O
of	O
the	O
infectious	O
dose	O
of	O
S.	O
aureus	I:C0038172
was	O
directly	O
through	O
the	O
teat	O
lactiferous	O
duct	I:C0222613
without	O
invasive	O
scraping	B:C0405377
of	I:C0405377
the	I:C0405377
teat	I:C0405377
surface	I:C0405377
.	O

Both	O
bacteriological	B:C0004642
and	O
histological	O
methods	I:C0019637
were	O
used	O
for	O
analysis	O
of	O
mammary	O
gland	I:C0929301
pathology	O
of	O
mice	O
post	O
-	O
infection	O
.	O

Both	O
bacteriological	O
and	O
histological	B:C0019637
methods	I:C0019637
were	O
used	O
for	O
analysis	O
of	O
mammary	O
gland	I:C0929301
pathology	O
of	O
mice	O
post	O
-	O
infection	O
.	O

Both	O
bacteriological	O
and	O
histological	O
methods	I:C0019637
were	O
used	O
for	O
analysis	B:C0936012
of	O
mammary	O
gland	I:C0929301
pathology	O
of	O
mice	O
post	O
-	O
infection	O
.	O

Both	O
bacteriological	O
and	O
histological	O
methods	I:C0019637
were	O
used	O
for	O
analysis	O
of	O
mammary	B:C0929301
gland	I:C0929301
pathology	O
of	O
mice	O
post	O
-	O
infection	O
.	O

Both	O
bacteriological	O
and	O
histological	O
methods	I:C0019637
were	O
used	O
for	O
analysis	O
of	O
mammary	O
gland	I:C0929301
pathology	O
of	O
mice	B:C1522424
post	O
-	O
infection	O
.	O

Both	O
bacteriological	O
and	O
histological	O
methods	I:C0019637
were	O
used	O
for	O
analysis	O
of	O
mammary	O
gland	I:C0929301
pathology	O
of	O
mice	O
post	O
-	O
infection	B:C3714514
.	O

Histopathological	O
analysis	B:C0936012
of	O
the	O
infected	O
mammary	O
glands	I:C0929301
revealed	O
that	O
mice	O
inoculated	O
with	O
the	O
strong	O
biofilm	O
forming	I:C1325881
S.	O
aureus	I:C0038172
strain	O
produced	O
marked	O
acute	O
mastitic	I:C0149613
lesions	O
,	O
showing	O
profuse	O
infiltration	O
predominantly	O
with	O
neutrophils	O
,	O
with	O
evidence	O
of	O
necrosis	O
in	O
the	O
affected	O
mammary	O
glands	I:C0929301
.	O

Histopathological	O
analysis	O
of	O
the	O
infected	B:C0439663
mammary	O
glands	I:C0929301
revealed	O
that	O
mice	O
inoculated	O
with	O
the	O
strong	O
biofilm	O
forming	I:C1325881
S.	O
aureus	I:C0038172
strain	O
produced	O
marked	O
acute	O
mastitic	I:C0149613
lesions	O
,	O
showing	O
profuse	O
infiltration	O
predominantly	O
with	O
neutrophils	O
,	O
with	O
evidence	O
of	O
necrosis	O
in	O
the	O
affected	O
mammary	O
glands	I:C0929301
.	O

Histopathological	O
analysis	O
of	O
the	O
infected	O
mammary	B:C0929301
glands	I:C0929301
revealed	O
that	O
mice	O
inoculated	O
with	O
the	O
strong	O
biofilm	O
forming	I:C1325881
S.	O
aureus	I:C0038172
strain	O
produced	O
marked	O
acute	O
mastitic	I:C0149613
lesions	O
,	O
showing	O
profuse	O
infiltration	O
predominantly	O
with	O
neutrophils	O
,	O
with	O
evidence	O
of	O
necrosis	O
in	O
the	O
affected	O
mammary	O
glands	I:C0929301
.	O

Histopathological	O
analysis	O
of	O
the	O
infected	O
mammary	O
glands	I:C0929301
revealed	O
that	O
mice	B:C1522424
inoculated	O
with	O
the	O
strong	O
biofilm	O
forming	I:C1325881
S.	O
aureus	I:C0038172
strain	O
produced	O
marked	O
acute	O
mastitic	I:C0149613
lesions	O
,	O
showing	O
profuse	O
infiltration	O
predominantly	O
with	O
neutrophils	O
,	O
with	O
evidence	O
of	O
necrosis	O
in	O
the	O
affected	O
mammary	O
glands	I:C0929301
.	O

Histopathological	O
analysis	O
of	O
the	O
infected	O
mammary	O
glands	I:C0929301
revealed	O
that	O
mice	O
inoculated	B:C2987620
with	O
the	O
strong	O
biofilm	O
forming	I:C1325881
S.	O
aureus	I:C0038172
strain	O
produced	O
marked	O
acute	O
mastitic	I:C0149613
lesions	O
,	O
showing	O
profuse	O
infiltration	O
predominantly	O
with	O
neutrophils	O
,	O
with	O
evidence	O
of	O
necrosis	O
in	O
the	O
affected	O
mammary	O
glands	I:C0929301
.	O

Histopathological	O
analysis	O
of	O
the	O
infected	O
mammary	O
glands	I:C0929301
revealed	O
that	O
mice	O
inoculated	O
with	O
the	O
strong	O
biofilm	B:C1325881
forming	I:C1325881
S.	O
aureus	I:C0038172
strain	O
produced	O
marked	O
acute	O
mastitic	I:C0149613
lesions	O
,	O
showing	O
profuse	O
infiltration	O
predominantly	O
with	O
neutrophils	O
,	O
with	O
evidence	O
of	O
necrosis	O
in	O
the	O
affected	O
mammary	O
glands	I:C0929301
.	O

Histopathological	O
analysis	O
of	O
the	O
infected	O
mammary	O
glands	I:C0929301
revealed	O
that	O
mice	O
inoculated	O
with	O
the	O
strong	O
biofilm	O
forming	I:C1325881
S.	B:C0038172
aureus	I:C0038172
strain	O
produced	O
marked	O
acute	O
mastitic	I:C0149613
lesions	O
,	O
showing	O
profuse	O
infiltration	O
predominantly	O
with	O
neutrophils	O
,	O
with	O
evidence	O
of	O
necrosis	O
in	O
the	O
affected	O
mammary	O
glands	I:C0929301
.	O

Histopathological	O
analysis	O
of	O
the	O
infected	O
mammary	O
glands	I:C0929301
revealed	O
that	O
mice	O
inoculated	O
with	O
the	O
strong	O
biofilm	O
forming	I:C1325881
S.	O
aureus	I:C0038172
strain	O
produced	O
marked	O
acute	B:C0149613
mastitic	I:C0149613
lesions	O
,	O
showing	O
profuse	O
infiltration	O
predominantly	O
with	O
neutrophils	O
,	O
with	O
evidence	O
of	O
necrosis	O
in	O
the	O
affected	O
mammary	O
glands	I:C0929301
.	O

Histopathological	O
analysis	O
of	O
the	O
infected	O
mammary	O
glands	I:C0929301
revealed	O
that	O
mice	O
inoculated	O
with	O
the	O
strong	O
biofilm	O
forming	I:C1325881
S.	O
aureus	I:C0038172
strain	O
produced	O
marked	O
acute	O
mastitic	I:C0149613
lesions	B:C0221198
,	O
showing	O
profuse	O
infiltration	O
predominantly	O
with	O
neutrophils	O
,	O
with	O
evidence	O
of	O
necrosis	O
in	O
the	O
affected	O
mammary	O
glands	I:C0929301
.	O

Histopathological	O
analysis	O
of	O
the	O
infected	O
mammary	O
glands	I:C0929301
revealed	O
that	O
mice	O
inoculated	O
with	O
the	O
strong	O
biofilm	O
forming	I:C1325881
S.	O
aureus	I:C0038172
strain	O
produced	O
marked	O
acute	O
mastitic	I:C0149613
lesions	O
,	O
showing	O
profuse	O
infiltration	B:C0332448
predominantly	O
with	O
neutrophils	O
,	O
with	O
evidence	O
of	O
necrosis	O
in	O
the	O
affected	O
mammary	O
glands	I:C0929301
.	O

Histopathological	O
analysis	O
of	O
the	O
infected	O
mammary	O
glands	I:C0929301
revealed	O
that	O
mice	O
inoculated	O
with	O
the	O
strong	O
biofilm	O
forming	I:C1325881
S.	O
aureus	I:C0038172
strain	O
produced	O
marked	O
acute	O
mastitic	I:C0149613
lesions	O
,	O
showing	O
profuse	O
infiltration	O
predominantly	O
with	O
neutrophils	B:C0027950
,	O
with	O
evidence	O
of	O
necrosis	O
in	O
the	O
affected	O
mammary	O
glands	I:C0929301
.	O

Histopathological	O
analysis	O
of	O
the	O
infected	O
mammary	O
glands	I:C0929301
revealed	O
that	O
mice	O
inoculated	O
with	O
the	O
strong	O
biofilm	O
forming	I:C1325881
S.	O
aureus	I:C0038172
strain	O
produced	O
marked	O
acute	O
mastitic	I:C0149613
lesions	O
,	O
showing	O
profuse	O
infiltration	O
predominantly	O
with	O
neutrophils	O
,	O
with	O
evidence	O
of	O
necrosis	B:C0027540
in	O
the	O
affected	O
mammary	O
glands	I:C0929301
.	O

Histopathological	O
analysis	O
of	O
the	O
infected	O
mammary	O
glands	I:C0929301
revealed	O
that	O
mice	O
inoculated	O
with	O
the	O
strong	O
biofilm	O
forming	I:C1325881
S.	O
aureus	I:C0038172
strain	O
produced	O
marked	O
acute	O
mastitic	I:C0149613
lesions	O
,	O
showing	O
profuse	O
infiltration	O
predominantly	O
with	O
neutrophils	O
,	O
with	O
evidence	O
of	O
necrosis	O
in	O
the	O
affected	O
mammary	B:C0929301
glands	I:C0929301
.	O

In	O
contrast	O
,	O
the	O
damage	B:C0010957
was	O
significantly	O
less	O
severe	O
in	O
mammary	O
glands	I:C0929301
of	O
mice	O
infected	O
with	O
the	O
weak	O
biofilm	O
-	I:C1325881
forming	I:C1325881
S.	O
aureus	I:C0038172
strain	O
.	O

In	O
contrast	O
,	O
the	O
damage	O
was	O
significantly	O
less	O
severe	O
in	O
mammary	B:C0929301
glands	I:C0929301
of	O
mice	O
infected	O
with	O
the	O
weak	O
biofilm	O
-	I:C1325881
forming	I:C1325881
S.	O
aureus	I:C0038172
strain	O
.	O

In	O
contrast	O
,	O
the	O
damage	O
was	O
significantly	O
less	O
severe	O
in	O
mammary	O
glands	I:C0929301
of	O
mice	B:C1522424
infected	O
with	O
the	O
weak	O
biofilm	O
-	I:C1325881
forming	I:C1325881
S.	O
aureus	I:C0038172
strain	O
.	O

In	O
contrast	O
,	O
the	O
damage	O
was	O
significantly	O
less	O
severe	O
in	O
mammary	O
glands	I:C0929301
of	O
mice	O
infected	B:C0439663
with	O
the	O
weak	O
biofilm	O
-	I:C1325881
forming	I:C1325881
S.	O
aureus	I:C0038172
strain	O
.	O

In	O
contrast	O
,	O
the	O
damage	O
was	O
significantly	O
less	O
severe	O
in	O
mammary	O
glands	I:C0929301
of	O
mice	O
infected	O
with	O
the	O
weak	O
biofilm	B:C1325881
-	I:C1325881
forming	I:C1325881
S.	O
aureus	I:C0038172
strain	O
.	O

In	O
contrast	O
,	O
the	O
damage	O
was	O
significantly	O
less	O
severe	O
in	O
mammary	O
glands	I:C0929301
of	O
mice	O
infected	O
with	O
the	O
weak	O
biofilm	O
-	I:C1325881
forming	I:C1325881
S.	B:C0038172
aureus	I:C0038172
strain	O
.	O

Although	O
both	O
IL	B:C0021753
-	I:C0021753
1	I:C0021753
β	I:C0021753
and	O
TNF	O
-α	I:C1456820
inflammatory	O
biomarkers	O
were	O
produced	O
in	O
infected	O
mice	O
,	O
level	O
of	O
TNF	O
-α	I:C1456820
produced	O
was	O
significantly	O
higher	O
(	O
p<0.05	O
)	O
in	O
mice	O
inoculated	O
with	O
strong	O
biofilm	O
forming	I:C1325881
S.	O
aureus	I:C0038172
than	O
the	O
weak	O
biofilm	O
forming	I:C1325881
strain	O
.	O

Although	O
both	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
and	O
TNF	B:C1456820
-α	I:C1456820
inflammatory	O
biomarkers	O
were	O
produced	O
in	O
infected	O
mice	O
,	O
level	O
of	O
TNF	O
-α	I:C1456820
produced	O
was	O
significantly	O
higher	O
(	O
p<0.05	O
)	O
in	O
mice	O
inoculated	O
with	O
strong	O
biofilm	O
forming	I:C1325881
S.	O
aureus	I:C0038172
than	O
the	O
weak	O
biofilm	O
forming	I:C1325881
strain	O
.	O

Although	O
both	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
and	O
TNF	O
-α	I:C1456820
inflammatory	O
biomarkers	B:C0005516
were	O
produced	O
in	O
infected	O
mice	O
,	O
level	O
of	O
TNF	O
-α	I:C1456820
produced	O
was	O
significantly	O
higher	O
(	O
p<0.05	O
)	O
in	O
mice	O
inoculated	O
with	O
strong	O
biofilm	O
forming	I:C1325881
S.	O
aureus	I:C0038172
than	O
the	O
weak	O
biofilm	O
forming	I:C1325881
strain	O
.	O

Although	O
both	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
and	O
TNF	O
-α	I:C1456820
inflammatory	O
biomarkers	O
were	O
produced	O
in	O
infected	B:C0439663
mice	O
,	O
level	O
of	O
TNF	O
-α	I:C1456820
produced	O
was	O
significantly	O
higher	O
(	O
p<0.05	O
)	O
in	O
mice	O
inoculated	O
with	O
strong	O
biofilm	O
forming	I:C1325881
S.	O
aureus	I:C0038172
than	O
the	O
weak	O
biofilm	O
forming	I:C1325881
strain	O
.	O

Although	O
both	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
and	O
TNF	O
-α	I:C1456820
inflammatory	O
biomarkers	O
were	O
produced	O
in	O
infected	O
mice	B:C1522424
,	O
level	O
of	O
TNF	O
-α	I:C1456820
produced	O
was	O
significantly	O
higher	O
(	O
p<0.05	O
)	O
in	O
mice	O
inoculated	O
with	O
strong	O
biofilm	O
forming	I:C1325881
S.	O
aureus	I:C0038172
than	O
the	O
weak	O
biofilm	O
forming	I:C1325881
strain	O
.	O

Although	O
both	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
and	O
TNF	O
-α	I:C1456820
inflammatory	O
biomarkers	O
were	O
produced	O
in	O
infected	O
mice	O
,	O
level	O
of	O
TNF	B:C1456820
-α	I:C1456820
produced	O
was	O
significantly	O
higher	O
(	O
p<0.05	O
)	O
in	O
mice	O
inoculated	O
with	O
strong	O
biofilm	O
forming	I:C1325881
S.	O
aureus	I:C0038172
than	O
the	O
weak	O
biofilm	O
forming	I:C1325881
strain	O
.	O

Although	O
both	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
and	O
TNF	O
-α	I:C1456820
inflammatory	O
biomarkers	O
were	O
produced	O
in	O
infected	O
mice	O
,	O
level	O
of	O
TNF	O
-α	I:C1456820
produced	O
was	O
significantly	O
higher	O
(	O
p<0.05	O
)	O
in	O
mice	B:C1522424
inoculated	O
with	O
strong	O
biofilm	O
forming	I:C1325881
S.	O
aureus	I:C0038172
than	O
the	O
weak	O
biofilm	O
forming	I:C1325881
strain	O
.	O

Although	O
both	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
and	O
TNF	O
-α	I:C1456820
inflammatory	O
biomarkers	O
were	O
produced	O
in	O
infected	O
mice	O
,	O
level	O
of	O
TNF	O
-α	I:C1456820
produced	O
was	O
significantly	O
higher	O
(	O
p<0.05	O
)	O
in	O
mice	O
inoculated	B:C2987620
with	O
strong	O
biofilm	O
forming	I:C1325881
S.	O
aureus	I:C0038172
than	O
the	O
weak	O
biofilm	O
forming	I:C1325881
strain	O
.	O

Although	O
both	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
and	O
TNF	O
-α	I:C1456820
inflammatory	O
biomarkers	O
were	O
produced	O
in	O
infected	O
mice	O
,	O
level	O
of	O
TNF	O
-α	I:C1456820
produced	O
was	O
significantly	O
higher	O
(	O
p<0.05	O
)	O
in	O
mice	O
inoculated	O
with	O
strong	O
biofilm	B:C1325881
forming	I:C1325881
S.	O
aureus	I:C0038172
than	O
the	O
weak	O
biofilm	O
forming	I:C1325881
strain	O
.	O

Although	O
both	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
and	O
TNF	O
-α	I:C1456820
inflammatory	O
biomarkers	O
were	O
produced	O
in	O
infected	O
mice	O
,	O
level	O
of	O
TNF	O
-α	I:C1456820
produced	O
was	O
significantly	O
higher	O
(	O
p<0.05	O
)	O
in	O
mice	O
inoculated	O
with	O
strong	O
biofilm	O
forming	I:C1325881
S.	B:C0038172
aureus	I:C0038172
than	O
the	O
weak	O
biofilm	O
forming	I:C1325881
strain	O
.	O

Although	O
both	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
and	O
TNF	O
-α	I:C1456820
inflammatory	O
biomarkers	O
were	O
produced	O
in	O
infected	O
mice	O
,	O
level	O
of	O
TNF	O
-α	I:C1456820
produced	O
was	O
significantly	O
higher	O
(	O
p<0.05	O
)	O
in	O
mice	O
inoculated	O
with	O
strong	O
biofilm	O
forming	I:C1325881
S.	O
aureus	I:C0038172
than	O
the	O
weak	O
biofilm	B:C1325881
forming	I:C1325881
strain	O
.	O

This	O
finding	B:C0243095
suggests	O
an	O
important	O
role	O
of	O
TNF	O
-α	I:C1456820
in	O
mammary	O
gland	I:C0929301
pathology	O
post	O
-	O
infection	O
with	O
strong	O
biofilm	O
-	I:C1325881
forming	I:C1325881
S.	O
aureus	I:C0038172
in	O
the	O
acute	O
mouse	I:C0149613
mastitis	I:C0149613
model	O
,	O
and	O
offers	O
an	O
opportunity	O
for	O
the	O
development	O
of	O
novel	O
strategies	O
for	O
reduction	O
of	O
mammary	O
tissue	O
damage	I:C0010957
,	O
with	O
or	O
without	O
use	O
of	O
antimicrobials	O
and	O
/	O
or	O
anti-inflammatory	O
compounds	I:C0003209
for	O
the	O
treatment	O
of	O
bovine	O
mastitis	I:C0024895
.	O

This	O
finding	O
suggests	O
an	O
important	O
role	O
of	O
TNF	B:C1456820
-α	I:C1456820
in	O
mammary	O
gland	I:C0929301
pathology	O
post	O
-	O
infection	O
with	O
strong	O
biofilm	O
-	I:C1325881
forming	I:C1325881
S.	O
aureus	I:C0038172
in	O
the	O
acute	O
mouse	I:C0149613
mastitis	I:C0149613
model	O
,	O
and	O
offers	O
an	O
opportunity	O
for	O
the	O
development	O
of	O
novel	O
strategies	O
for	O
reduction	O
of	O
mammary	O
tissue	O
damage	I:C0010957
,	O
with	O
or	O
without	O
use	O
of	O
antimicrobials	O
and	O
/	O
or	O
anti-inflammatory	O
compounds	I:C0003209
for	O
the	O
treatment	O
of	O
bovine	O
mastitis	I:C0024895
.	O

This	O
finding	O
suggests	O
an	O
important	O
role	O
of	O
TNF	O
-α	I:C1456820
in	O
mammary	B:C0929301
gland	I:C0929301
pathology	O
post	O
-	O
infection	O
with	O
strong	O
biofilm	O
-	I:C1325881
forming	I:C1325881
S.	O
aureus	I:C0038172
in	O
the	O
acute	O
mouse	I:C0149613
mastitis	I:C0149613
model	O
,	O
and	O
offers	O
an	O
opportunity	O
for	O
the	O
development	O
of	O
novel	O
strategies	O
for	O
reduction	O
of	O
mammary	O
tissue	O
damage	I:C0010957
,	O
with	O
or	O
without	O
use	O
of	O
antimicrobials	O
and	O
/	O
or	O
anti-inflammatory	O
compounds	I:C0003209
for	O
the	O
treatment	O
of	O
bovine	O
mastitis	I:C0024895
.	O

This	O
finding	O
suggests	O
an	O
important	O
role	O
of	O
TNF	O
-α	I:C1456820
in	O
mammary	O
gland	I:C0929301
pathology	O
post	O
-	O
infection	B:C3714514
with	O
strong	O
biofilm	O
-	I:C1325881
forming	I:C1325881
S.	O
aureus	I:C0038172
in	O
the	O
acute	O
mouse	I:C0149613
mastitis	I:C0149613
model	O
,	O
and	O
offers	O
an	O
opportunity	O
for	O
the	O
development	O
of	O
novel	O
strategies	O
for	O
reduction	O
of	O
mammary	O
tissue	O
damage	I:C0010957
,	O
with	O
or	O
without	O
use	O
of	O
antimicrobials	O
and	O
/	O
or	O
anti-inflammatory	O
compounds	I:C0003209
for	O
the	O
treatment	O
of	O
bovine	O
mastitis	I:C0024895
.	O

This	O
finding	O
suggests	O
an	O
important	O
role	O
of	O
TNF	O
-α	I:C1456820
in	O
mammary	O
gland	I:C0929301
pathology	O
post	O
-	O
infection	O
with	O
strong	O
biofilm	B:C1325881
-	I:C1325881
forming	I:C1325881
S.	O
aureus	I:C0038172
in	O
the	O
acute	O
mouse	I:C0149613
mastitis	I:C0149613
model	O
,	O
and	O
offers	O
an	O
opportunity	O
for	O
the	O
development	O
of	O
novel	O
strategies	O
for	O
reduction	O
of	O
mammary	O
tissue	O
damage	I:C0010957
,	O
with	O
or	O
without	O
use	O
of	O
antimicrobials	O
and	O
/	O
or	O
anti-inflammatory	O
compounds	I:C0003209
for	O
the	O
treatment	O
of	O
bovine	O
mastitis	I:C0024895
.	O

This	O
finding	O
suggests	O
an	O
important	O
role	O
of	O
TNF	O
-α	I:C1456820
in	O
mammary	O
gland	I:C0929301
pathology	O
post	O
-	O
infection	O
with	O
strong	O
biofilm	O
-	I:C1325881
forming	I:C1325881
S.	B:C0038172
aureus	I:C0038172
in	O
the	O
acute	O
mouse	I:C0149613
mastitis	I:C0149613
model	O
,	O
and	O
offers	O
an	O
opportunity	O
for	O
the	O
development	O
of	O
novel	O
strategies	O
for	O
reduction	O
of	O
mammary	O
tissue	O
damage	I:C0010957
,	O
with	O
or	O
without	O
use	O
of	O
antimicrobials	O
and	O
/	O
or	O
anti-inflammatory	O
compounds	I:C0003209
for	O
the	O
treatment	O
of	O
bovine	O
mastitis	I:C0024895
.	O

This	O
finding	O
suggests	O
an	O
important	O
role	O
of	O
TNF	O
-α	I:C1456820
in	O
mammary	O
gland	I:C0929301
pathology	O
post	O
-	O
infection	O
with	O
strong	O
biofilm	O
-	I:C1325881
forming	I:C1325881
S.	O
aureus	I:C0038172
in	O
the	O
acute	B:C0149613
mouse	I:C0149613
mastitis	I:C0149613
model	O
,	O
and	O
offers	O
an	O
opportunity	O
for	O
the	O
development	O
of	O
novel	O
strategies	O
for	O
reduction	O
of	O
mammary	O
tissue	O
damage	I:C0010957
,	O
with	O
or	O
without	O
use	O
of	O
antimicrobials	O
and	O
/	O
or	O
anti-inflammatory	O
compounds	I:C0003209
for	O
the	O
treatment	O
of	O
bovine	O
mastitis	I:C0024895
.	O

This	O
finding	O
suggests	O
an	O
important	O
role	O
of	O
TNF	O
-α	I:C1456820
in	O
mammary	O
gland	I:C0929301
pathology	O
post	O
-	O
infection	O
with	O
strong	O
biofilm	O
-	I:C1325881
forming	I:C1325881
S.	O
aureus	I:C0038172
in	O
the	O
acute	O
mouse	I:C0149613
mastitis	I:C0149613
model	B:C0012644
,	O
and	O
offers	O
an	O
opportunity	O
for	O
the	O
development	O
of	O
novel	O
strategies	O
for	O
reduction	O
of	O
mammary	O
tissue	O
damage	I:C0010957
,	O
with	O
or	O
without	O
use	O
of	O
antimicrobials	O
and	O
/	O
or	O
anti-inflammatory	O
compounds	I:C0003209
for	O
the	O
treatment	O
of	O
bovine	O
mastitis	I:C0024895
.	O

This	O
finding	O
suggests	O
an	O
important	O
role	O
of	O
TNF	O
-α	I:C1456820
in	O
mammary	O
gland	I:C0929301
pathology	O
post	O
-	O
infection	O
with	O
strong	O
biofilm	O
-	I:C1325881
forming	I:C1325881
S.	O
aureus	I:C0038172
in	O
the	O
acute	O
mouse	I:C0149613
mastitis	I:C0149613
model	O
,	O
and	O
offers	O
an	O
opportunity	O
for	O
the	O
development	O
of	O
novel	O
strategies	O
for	O
reduction	B:C0441610
of	O
mammary	O
tissue	O
damage	I:C0010957
,	O
with	O
or	O
without	O
use	O
of	O
antimicrobials	O
and	O
/	O
or	O
anti-inflammatory	O
compounds	I:C0003209
for	O
the	O
treatment	O
of	O
bovine	O
mastitis	I:C0024895
.	O

This	O
finding	O
suggests	O
an	O
important	O
role	O
of	O
TNF	O
-α	I:C1456820
in	O
mammary	O
gland	I:C0929301
pathology	O
post	O
-	O
infection	O
with	O
strong	O
biofilm	O
-	I:C1325881
forming	I:C1325881
S.	O
aureus	I:C0038172
in	O
the	O
acute	O
mouse	I:C0149613
mastitis	I:C0149613
model	O
,	O
and	O
offers	O
an	O
opportunity	O
for	O
the	O
development	O
of	O
novel	O
strategies	O
for	O
reduction	O
of	O
mammary	B:C0006141
tissue	O
damage	I:C0010957
,	O
with	O
or	O
without	O
use	O
of	O
antimicrobials	O
and	O
/	O
or	O
anti-inflammatory	O
compounds	I:C0003209
for	O
the	O
treatment	O
of	O
bovine	O
mastitis	I:C0024895
.	O

This	O
finding	O
suggests	O
an	O
important	O
role	O
of	O
TNF	O
-α	I:C1456820
in	O
mammary	O
gland	I:C0929301
pathology	O
post	O
-	O
infection	O
with	O
strong	O
biofilm	O
-	I:C1325881
forming	I:C1325881
S.	O
aureus	I:C0038172
in	O
the	O
acute	O
mouse	I:C0149613
mastitis	I:C0149613
model	O
,	O
and	O
offers	O
an	O
opportunity	O
for	O
the	O
development	O
of	O
novel	O
strategies	O
for	O
reduction	O
of	O
mammary	O
tissue	B:C0010957
damage	I:C0010957
,	O
with	O
or	O
without	O
use	O
of	O
antimicrobials	O
and	O
/	O
or	O
anti-inflammatory	O
compounds	I:C0003209
for	O
the	O
treatment	O
of	O
bovine	O
mastitis	I:C0024895
.	O

This	O
finding	O
suggests	O
an	O
important	O
role	O
of	O
TNF	O
-α	I:C1456820
in	O
mammary	O
gland	I:C0929301
pathology	O
post	O
-	O
infection	O
with	O
strong	O
biofilm	O
-	I:C1325881
forming	I:C1325881
S.	O
aureus	I:C0038172
in	O
the	O
acute	O
mouse	I:C0149613
mastitis	I:C0149613
model	O
,	O
and	O
offers	O
an	O
opportunity	O
for	O
the	O
development	O
of	O
novel	O
strategies	O
for	O
reduction	O
of	O
mammary	O
tissue	O
damage	I:C0010957
,	O
with	O
or	O
without	O
use	O
of	O
antimicrobials	B:C1136254
and	O
/	O
or	O
anti-inflammatory	O
compounds	I:C0003209
for	O
the	O
treatment	O
of	O
bovine	O
mastitis	I:C0024895
.	O

This	O
finding	O
suggests	O
an	O
important	O
role	O
of	O
TNF	O
-α	I:C1456820
in	O
mammary	O
gland	I:C0929301
pathology	O
post	O
-	O
infection	O
with	O
strong	O
biofilm	O
-	I:C1325881
forming	I:C1325881
S.	O
aureus	I:C0038172
in	O
the	O
acute	O
mouse	I:C0149613
mastitis	I:C0149613
model	O
,	O
and	O
offers	O
an	O
opportunity	O
for	O
the	O
development	O
of	O
novel	O
strategies	O
for	O
reduction	O
of	O
mammary	O
tissue	O
damage	I:C0010957
,	O
with	O
or	O
without	O
use	O
of	O
antimicrobials	O
and	O
/	O
or	O
anti-inflammatory	B:C0003209
compounds	I:C0003209
for	O
the	O
treatment	O
of	O
bovine	O
mastitis	I:C0024895
.	O

This	O
finding	O
suggests	O
an	O
important	O
role	O
of	O
TNF	O
-α	I:C1456820
in	O
mammary	O
gland	I:C0929301
pathology	O
post	O
-	O
infection	O
with	O
strong	O
biofilm	O
-	I:C1325881
forming	I:C1325881
S.	O
aureus	I:C0038172
in	O
the	O
acute	O
mouse	I:C0149613
mastitis	I:C0149613
model	O
,	O
and	O
offers	O
an	O
opportunity	O
for	O
the	O
development	O
of	O
novel	O
strategies	O
for	O
reduction	O
of	O
mammary	O
tissue	O
damage	I:C0010957
,	O
with	O
or	O
without	O
use	O
of	O
antimicrobials	O
and	O
/	O
or	O
anti-inflammatory	O
compounds	I:C0003209
for	O
the	O
treatment	B:C0087111
of	O
bovine	O
mastitis	I:C0024895
.	O

This	O
finding	O
suggests	O
an	O
important	O
role	O
of	O
TNF	O
-α	I:C1456820
in	O
mammary	O
gland	I:C0929301
pathology	O
post	O
-	O
infection	O
with	O
strong	O
biofilm	O
-	I:C1325881
forming	I:C1325881
S.	O
aureus	I:C0038172
in	O
the	O
acute	O
mouse	I:C0149613
mastitis	I:C0149613
model	O
,	O
and	O
offers	O
an	O
opportunity	O
for	O
the	O
development	O
of	O
novel	O
strategies	O
for	O
reduction	O
of	O
mammary	O
tissue	O
damage	I:C0010957
,	O
with	O
or	O
without	O
use	O
of	O
antimicrobials	O
and	O
/	O
or	O
anti-inflammatory	O
compounds	I:C0003209
for	O
the	O
treatment	O
of	O
bovine	B:C0024895
mastitis	I:C0024895
.	O

